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ABSTRAK (VERSI BAHASA MELAYU) 
  
 
FAKTOR-FAKTOR YANG MEMPENGARUHI HIPERTENSI DI KALANGAN 
WANITA MENOPOS SELEPAS PEMBEDAHAN DI HOSPITAL UNIVERSITI 
SAINS MALAYSIA 
 
Pengenalan:  
 
Menopos selepas pembedahan seperti pembuangan rahim dan kedua-dua ovari yang 
menyebabkan ketiadaan period secara mengejut. Ia menyebabkan risiko untuk 
mendapat hipertensi mendadak naik sama seperti kaum lelaki, dengan itu risiko untuk 
dapat penyakit jantung pun meningkat. 
 
Objektif :  
 
Untuk mengkaji kaitan antara wanita menopos selepas pembedahan dengan hipertensi. 
 
 
 
 
 ix 
 
Kaedah Kajian : 
 
Satu kajian retrospective yang dilaksanakan di kalangan wanita selepas pembedahan 
pembuangan rahim dan kedua-dua ovari atau kedua-dua ovari sahaja yang mendapatkan 
rawatan di klinik sakit puan di Hospital Univesity Sains Malaysia yang berumur kurang 
daripada 50 tahun. Faktor-faktor yang dikaji termasuk BMI, bangsa, jumlah kelahiran 
anak, HRT, sejarah penyakit  sendiri seperti kencing manis atau sakit jantung dan 
sejarah penyakit dalam keluarga. 
 
Kesimpulan:  
 
Purata umur yang dikaji ialah 46.2 tahun. Dalam kajian ini, didapati pesakit yang 
menjalani pembedahan TAHBSO ialah 97 %, sementara BSO hanya 3 %. Majoriti  
penyebab pembedahan di kalangan pesakit adalah Fibroid (86.7%) diikuti oleh 
‘adenomyosis’(5.6%), dan endometriosis (4.3%). Dari kajian ini dapat disimpulkan. 
bahawa bangsa, berat badan, jumlah kelahiran anak,  HRT, sejarah penyakit  sendiri 
seperti kencing manis atau sakit jantung, atau sejarah penyakit dalam keluarga seperti  
hypertensi, Diabetis Mellitus dan penyakit jantung adalah tidak mempengaruhi 
berlakunya hypertensi (p>0.050). Akan tetapi, median masa untuk mendapatkan bila 
akan berlaku hypertensi dalam kajian ini tidak dapat diinterpretasikan kerana kejadian 
berlakunya hipertensi adalah kurang dari 50%. 
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ABSTRACT (ENGLISH VERSION) 
 
 
FACTORS ASSOCIATED WITH THE DEVELOPMENT OF HYPERTENSION 
AMONG SURGICAL MENOPAUSAL WOMEN AT HOSPITAL UNIVERSITI 
SAINS MALAYSIA  
 
Introduction:  
 
Surgical menopause defined as attained menopause after surgically removal of uterus 
with bilateral oopherectomy or removal of both ovaries only. Surgical menopause 
increases the risk of development of hypertension which is predisposed to the 
development of the cardiovascular complications. 
 
Objective:  
 
To determined factors associated with the development of hypertension among post-
surgical menopausal women. 
 
 
 
 
 xi 
 
Method:  
 
A Retrospective study of all surgical menopausal women that was conducted in 
Hospital University Sains Malaysia. It involved all 301 patients who was surgically 
menopause and age less than 50 years , attending Gynaecology clinic at HUSM. Race, 
hormone replacement therapy (HRT), parity, body mass index (BMI), underlying 
medical illness (diabetes Mellitus(DM )and Cardiovascular Disease (CVS) ), smoking 
status, family history of hypertension, DM and CVS, were recorded retrospectively 
from medical record . 
 
Result:  
 
The mean age of the patients was 46.2 years old. In this study, we found that most 
patients had gone through TAHBSO (97.0%) while another three percent (3%) had 
BSO. The majority of women had a fibroid (86.7%), followed by adenomyosis (5.6%) 
and endometriosis (4.3%), However, there is no significant association among the 
factors investigated which include race, age, BMI, parity, HRT, underlying medical 
illness (DM and CVS), smoking status, family history of hypertension, DM and CVS 
(p>0.050).   Median hypertension survival time could not be reported as hypertensive 
events occurred less than 50% and the survival probability did not drop to 0.5 (50%) or 
below. No median survival because most patients survives hypertension. 
 
 
 
 
 xii 
 
Conclusion: 
 
 
The mean age of patient involved in this study was 46.2 years , 97% of patient had 
undergone TAHBSO and only 3% BSO. There were no significant relationship between 
hypertension with race, BMI, parity, history of taking HRT, underlying medical illness 
(DM and CVS), smoking status, family history of hypertension, DM and CVS. There is 
no median survival rate for hypertension in post-menopausal group as the median 
hypertension survival time could not be reported as hypertensive events occurred less 
than 50% and the survival probability did not drop to 0.5 (50%) or below. No median 
survival because most patients survive hypertension.  
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1.0 INTRODUCTION 
 
 
1.1 Menopause 
 
1.1.1 Definition 
 
Menopause is a natural process which is defined as cessation of menses. It is diagnosed 
retrospectively after 12 consecutive months of amenorrhea  for which no other 
pathological or physiological cause of menopause (World Health Organization, 1981; 
Kaufert et al., 1986; McKinlay et al., 1985).  
 
Menopause marks the end of reproductive life. Menopause usually occurs naturally in 
women, or it might be induced surgically after hysterectomy with bilateral 
oophorectomy or bilateral salpingo-oophorectomy. Surgically induced menopause is 
termed as surgical menopause.  Natural menopause usually undergoes three transition 
stages; Premenopause, Perimenopause, Postmenopause.  
 
The premenopausal state is defined as menstruation within the prior three months, with 
no change in the regularity of cycle. Perimenopausal involved the change in cycle 
regularity or three to eleventh months of amenorrhea. The postmenopausal state consists 
of permanent amenorrhea which is diagnosed retrospectively.   
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1.1.2 Changes in Hormone Metabolism Associated With Menopause 
 
Following menopause, there are major changes in androgen, estrogen, progesterone and 
gonadotrophin secretion following the cessation of ovarian follicular activity (Burger et 
al., 2002). In postmenopausal women, there is a reduction in circulating 
androstenedione to approximately 50% of the concentration found in young women. 
The main estrogen in postmenopausal women is estrone, which mostly derived from 
peripheral aromatization of androstenedione.   
 
The level of progesterone is also low in post-menopausal women, the level only 30% 
seen in young women during the follicular phase. Both Luteinising Hormone (LH) and 
Follicular Stimulating Hormone (FSH) levels rise with FSH markedly higher than LH. 
The marked increase in circulating gonadotrophin is due to the absence of negative 
feedback of ovarian steroids hormone and inhibin on gonadotrophin-release hormone 
(Margerat, 2003). Hypertension is a major predisposing factor for developing 
cardiovascular disease, especially in a post-menopausal women.  
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1.1.3 Sequelae of Ovarian Failure 
 
 
The short-term sequelae of menopause are vasomotor symptoms, mood disorder, 
urogenital and sexual dysfunction. A study on Malaysian menopause women indicate 
that only 30% of the complaints of menopausal symptom, of which 57 % of them were 
having   vasomotor symptom such as hot flushes ( Nik Nasri,1994). Hot flushes can 
happen at any time of the day or night. It disturbs sleep if it occur at night. Chronically 
deprived of sleep will lead to insomnia, irritability, difficulty in concentration and short-
term memory loss.  
 
The long-term complication included cardiovascular disease, osteoporosis and tissue 
atrophy (Brincat et al., 1987). 
 
1.1.4 Hormone Replacement Therapy (HRT) 
 
 
Hormone replacement therapy contains estrogen only or combined estrogen and 
progesterone, which can be given continuous or cyclical basis. HRT widely use in the 
management of climeteric symptoms such as hot flushes, night sweat, vaginal dryness 
and sleep disturbance . HRT can prevent postmenopausal bone loss and osteoporotic 
fracture in long-term usage.  
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1.2 Hypertension 
 
 
Definition 
 
Hypertension defined as persistent elevation of blood pressure greater than systolic 140 
or diastolic Blood pressure more than 90mmHg or taking medication (M Moser-Journal 
of clinical hypertension, 1999.). 
 
The American Heart Association recommends that need at least three resting 
measurements on at least two separate health care visits (Journal of the American 
Society of Hypertension: JASH.5 (4): 259-352.2011).    It is a risk factor for developing 
heart attack and cardiovascular disease. The incidence of cardiovascular disease and 
atherosclerotic diseases are higher in postmenopausal women (Tunstall-Pedoe H, 
Lancet 1998). 
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   1.3 JUSTIFICATION TO CONDUCT STUDY  
 
 
This retrospective study aims to evaluate the risk factors associated with the 
development of hypertension in post-surgical menopausal women attending 
gynaecology clinic in Hospital University Sains Malaysia.   
 
Previous studies mainly observe postmenopausal as a general population. There is no 
specific study regarding post-surgical menopause in relation to the development of 
hypertension and its associated factor.    This study is also important in describing the 
patterns of hypertension in our community. Also, awareness and knowledge of the study 
could be instituted and ultimately to improve the diseases , future management and 
quality of life in post surgical menopausal ladies.  
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     OF THE STUDY 1.4 BENEFITS 
 
 
Retrospectively, the information from this study is crucial to improve future 
management, plan of action and counselling to the patient in prevention and 
optimization of hypertensive control in post-surgical menopausal women. 
  
 19 
 
2.0 LITERATURE REVIEW 
 
 
Globally, life expectancy has improved from the year 2000 to 2015; 68.7 and 73.7 
years respectively. Life expectancy for a female is higher compared to male 
population. World Health Organization has noted that in 2015 female life expectancy 
was 73.7 years while, male life expectancy was 69.1 years (World Health 
Organization, 2015). 
 
 In  Malaysia life expectancy now reaches 77.4 years in women and 72.5 years in male 
(Department of statistic Malaysia,2015). Despite the improvement of women life 
expectancy, the average age of menopause remains at  47.96 years (Jahanfar et al., 
2006). Studies also have shown that the median age of menopause in Malaysia women 
is 48.7 years (Hamid et al., 1989) and 50.7 years (Nik Nasri, 1994).  
 
Women are now living more than one-third of life in menopausal years. Thus, it is 
important for the clinician to understand the hormonal and physiological changes of 
menopause and also psychological aspects that are associated with it. It is important in 
the preventing, identification and management of  related medical illness. 
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Following menopause, there are major changes in androgen, oestrogen, progesterone 
and gonadotrophin secretion, which occur due to the cessation of ovarian follicular 
activity (Burger et al., 2002).  
 
In postmenopausal women, there is a reduction in circulating androstenedione to 
approximately 50% of the concentration found in young women.The main estrogen in 
postmenopausal women is estrone, which largely derived from peripheral 
aromatization of androstenedione. 
 
 The level of progesterone is also low in post-menopausal women, being only 30% 
seen in young women during the follicular phase. Both LH and FSH levels rise with 
FSH markedly higher than LH. The marked increase in circulating gonadotrophin is 
due to the absence of negative feedback of ovarian steroids hormone and inhibin on 
gonadotrophin-release hormone (Margerat, 2003). 
 
The short-term sequelae are vasomotor symptoms, mood disorder, urogenital and 
sexual dysfunction. Study of menopause among Malaysian women only 30% of the 
complaints of menopausal symptom, 57 % were due to vasomotor symptom such as 
hot flushes 
( Nik Nasri,1994).  
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Hot flushes can happen any time of the day or night, which will disturb sleep at night. 
Chronically deprived of sleep will lead to insomnia, irritability, difficulty in 
concentration and short-term memory. 
 
 The long-term complication are cardiovascular disease, osteoporosis and tissue 
atrophy due to the deficiency of estrogen to support postmenopausal women (Brincat 
et al., 1987). 
 
Biological changes occurring as a result of menopause are difficult to evaluate since 
menopause coincides with ageing, and menopause and blood pressure are jointly 
influenced by factors, such as body mass index, socio-economy class and smoking.  
 
With the use of Cochren-Mantel-Haenszel method, both natural and surgical 
menopause were associated with 0.5 mmHg /year steeper rise in systolic blood 
pressure with age. Also, postmenopausal women, had an average of 2.3 mmHg higher 
diastolic blood pressure then premenopausal (Jan Staessen et al.,1989). 
 
Hypertension is estimated to cause 4.5% of the global disease burden and is as 
prevalent in many developing countries as in developed countries (WHO, International 
society of hypertension 2003). Worldwide, seven million premature deaths attributed 
to hypertension (WHO, The World Health Report: Reducing Risk, Promoting Healthy 
Life 2002). 
 
 22 
 
 In recent decades, it has become increasingly clear that the development of stroke, 
ischemic heart disease, and renal failure have been attributed to hypertension. Treating 
hypertension has been associated with a 40% reduction in the risk of stroke and about 
15% reduction in the risk of myocardial infarction (WHO, International society of 
hypertension 2003). 
 
There is a positive relationship between systolic blood pressure (SBP), diastolic blood 
pressure (DBP) and the risk of developing cardiovascular, cerebrovascular and renal 
diseases. Therefore the main aim of identifying and treating high BP is to reduce these 
risks. Hence BP should be measured at every clinic encounter (CPG, management of 
hypertension 3
rd
 edition 2008). 
 
Hypertension is a major risk factor for cardiovascular disease, which is the leading 
cause of mortality and morbidity in postmenopausal women (Wassertheil-Smoller et 
al., 2000). After menopause, the sharp increase in the prevalence of hypertension to 
levels that equal or surpass that of men suggest that premenopausal women state is 
protection against hypertension (Khalil RA. et al., 2005).  
 
There is evidence that blood pressure may not be as well-controlled in women as in 
men, despite the fact that most women adhere better to their therapeutic regimens and 
medications better  than men, and have their blood pressures measured more 
frequently than men. (Hypertension Journal, June 2012,Volume, Issue 3). 
Postmenopausal women have been shown more salt sensitive than premenopausal 
women (Myers K et al., 1983). 
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Postmenopausal was an independent risk factor for hypertension (Ying Zhou et al., 
2015).  Other known risk factors for hypertension included body mass index (BMI), 
abdominal obesity, family history of cardiovascular disease among the first-degree 
relatives, a personal history of diabetes, and high triglyceride (Ying Zhou et al., 2015). 
Menopause is also accompanied by weight gain ( Portaluppi. F et al, Hypertension 
1997). 
 
 The incidence of cardiovascular disease and atherosclerotic diseases are higher in 
postmenopausal women (Tunstall-Pedoe H, Lancet 1998) and hypertension is a known 
risk factor for cardiovascular disease. 
 
 Aging and natural menopause were difficult to define. When the exact timing of 
menopause is still unknown. This is due to the lack of concurrent measurement of 
hypothalamic and reproductive hormones to distinguish menopause from other cause 
of amenorrhea and differentiation between late pre-menopause, perimenopausal, and 
early menopause (Brittner V, 2009).However, in surgical menopause there is an abrupt 
cut off the supply of ovarian hormone especially endogenous estrogen. 
 
Surgical menopause causes abrupt loss of ovarian hormone, independent of ageing, 
was associated with the development of salt-sensitive in a substantive number of 
previously salt resistant women. Women are classified as salt-sensitive was 
significantly greater four months after surgical menopause (Schulman et al., 2006). 
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 After menopause, the loss of the ovarian hormones predisposes women to salt 
sensitive and hypertension that would be at higher risk for cardiovascular morbidity 
and mortality. 
 
The post menopausal estrogen deficiency may affect the balance between various 
vaso-active hormone and the proliferation and function of vascular smooth muscle 
cells, possibly by altering the electrolyte composition. Menopause through a 
redistribution of body sodium and the cessation of periods is followed by a rise in 
haemoglobin and in erythrocyte count (Hjortland MC. et al ,Am J Epidemiol 1976), 
therefore increasing blood viscocity and in turn possibly also blood pressure(Yarnell 
JWG et al,Circulatioin 1991). 
 
The present observation may have important implication for cardiovascular disease. 
Salt-sensitive hypertensive patient has a higher incidence of left ventricular 
hypertrophy, (Heimann JC et al., 1991) endothelial dysfunction, (Miyoshi A et al., 
1997) hyperlipidemia (Bigazzi R.et al.,1994), and  microalbuminemia (Bigazzi R et 
al.,1994 ) compare to the salt-resistant hypertensive patient. Also, an association 
between insulin resistance and salt sensitive in non-diabetic, non- obese, essential 
hypertensive subjects has been reported (Suzuki M et al., 2000).  
 
 
 
 
 25 
 
Estrogen therapy  after menopause demonstrate that correction of postmenapausal 
estrogen deficiency is accompanied by a decrease in the incidence of cardiovascular 
complication (JA Staessen et al, Journal of Human Hypertension,1998). 
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3.0 OBJECTIVES OF THE STUDY  
 
 
3.1 General Objective 
 
• To evaluate hypertension in surgical menopausal patients.  
 
3.2 Specific Objective 
 
• To determine the prevalence of hypertension among patients with surgical 
menopause at HUSM . 
 
• To determine the timing of onset of hypertension in post TAHBSO and BSO at  
HUSM. 
 
• To determine the factors associated with the onset of hypertension in post-
surgical menopause patients. 
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4.0 METHODOLOGY 
 
 
This study was a retrospective which was done in Hospital University Sains Malaysia. 
The record of all patients who had undergone TAHBSO from 1
st
 January 2000 to 31
st
 
December 2010 were reviewed.  
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4.1 Sample Size Calculation 
 
 
The estimated sample size for the third objective was calculated based on the study 
done in northeast China which stated that post menopause status was an independent 
risk factor for hypertension.(Ying Zhou et.al.2014) using PS software sample size with 
2 min formula. n = Zα 
Variable Α M P σ 
Δ (20% less fr 
SD) 
nx3 
 
Age 0.5 2 0.8 7.8 5 19 x 3 57 
BMI 0.5 2 0.8 3.9 3 19 x 3 57 
FBS 0.5 2 0.8 1.8 2 20 x 3 60 
n= sample size  
2 proportion formula  
Variable Α P M P0 P1 N  
Smoking 0.05 0.8 2 10 20 143 x 2 286 
 
Based on the above calculation, a minimal of 314 patients were needed to meet the 80% 
statistical power. 
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4.2 Inclusion criteria 
 
 
 All post total abdominal hysterectomy with bilateral oophorectomy or bilateral 
oophorectomy women for the benign disease at the age less than 50 years old and 
follow up at Gynecology clinic HUSM from January 2000 to December 2010. 
 
 
4.3 Exclusion criteria 
 
 
Patients with the following criteria were excluded from the study:  
1. Surgery performed for malignant disease. 
2. Pre-existing hypertension. 
3. Incomplete data. 
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4.4 Ethical and Consent 
 
 
An approval to conduct the study was obtained from the Human Research Ethics 
Committee USM (HREC). The consent to review the medical records was obtained 
from director of Hospital University Sains Malaysia.).  
 
 
4.5 Data Collection  
 
 
The list of patients who had undergone TAHBSO and BSO in Hospital University Sains 
Malaysia was obtained from the Hospital USM’s O&G clinic. The case notes of patients 
were obtained from the record office. Data was collected and entered in the Clinical 
Research Form as shown in Appendix : 1 
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4.6 Data Entry and Analysis 
 
 
All data were analysed using SPSS version 24. For descriptive analysis, continuous or 
numerical variables were described in mean and categorical variables were described in 
frequency and percentage (%). Data was analysed based on specific objectives. Chi-
Squared test and differences in mean were used for categorical and continuous 
variables. 
 
 To evaluate the association between measured variables such as the indication for 
operation, BMI, the age of operation, ethnic group, socioeconomic status, the age of 
menarche and parity of post-surgical menopausal patient. Multiple logistic regression 
and survival analysis were performed.  
 
All factors with the p value less than 0.05 (significant level) in the univariate analysis 
were included in the multivariate analysis. 
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4.7 FLOW CHART 
 
 
 
 
 
 
Figure 1: Study flow chart 
 
 
 
 
 
Data Analysis 
Data Entry in the CRF 
Case Notes of patients were traced from Record 
Office 
All post TAHBSO patients in Hospital USM 
• Inclusion 
Criteria 
• Exclusion 
Criteria 
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5.0  RESULTS 
 
 
5.1 Demographic data 
 
A total  of 301 patients were recruited into the study. The age of the patients recruited 
ranged from 30-50 years old. The mean age of the patients was 46.2 +/-2.99 years 
(Figure 2). 
 
 
Figure 2:  Histogram showing the age distribution of the patients.  
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Most of the patients had normal BMI ; with mean BMI of 26.0 +/- 6.5 kg/m2. The 
lowest BMI was 17 kg/m2 and the highest was 41.7 kg/m2. 
 
 
Figure 3 : Histogram showing distribution of BMI 
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79%  of the patients (n=238 ) were Malay, 18.94% (n=57 ) were Chinese and the rest 
(2.0% ,n=6) were Indian and Siamese (Figure 4).  
 
 
Figure 4 : Ethnicity of post -surgical menopausal patient at HUSM. 
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More than 90% of the patients had undergone TAHBSO (n=292 ; 97% ) and only 9 
patients (3.0%) underwent BSO. Table 1 shows the indications for the operations. 
 
Table 1: Types of operation and indication of surgical procedure among post-surgical 
menopausal women 
 
Variables  Post surgical menopausal women 
 n (%) 
Types of operation  
TAHBSO 292 (97.00) 
BSO  9 (3.00) 
  
Indication  
Fibroid 261 (86.71) 
Adenomyosis 17 (5.64) 
Endometriosis 13 (4.32) 
Bilateral teratoma 7 (2.33) 
Bilateral endometriosis 2 (0.66) 
Ovarian cyst 1 (0.34) 
TAHBSO: Total abdominal hysterectomy bilateral salpingo-oophorectomy 
BSO: Bilateral salpingo-oophorectomy 
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Most of the patient were nulliparous and had low parity , nulliparous 18.3% (n:55) 
,followed by parity four 16.9 % (n: 51), parity three ,16.3 % (n:49), parity one ,11.3% 
(n:34) 
 
 
 
 
 
Figure 5: Histogram showing the frequency of the parity of the patients 
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59.1% of the patients received Hormone Replacement Therapy (HRT) after operation 
(n:178). Otherwise 40.9% (n: 123) of patient did not received HRT.  
 
 
 
 
Figure 6: Pie chart showed the percentage of HRT in post operation patients. 
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5.2 Prevalence of hypertension 
Out of the 301 surgical menopause patients, only 82 of them (27.0%) were noted to 
have hypertension, as was shown in Figure 5 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Pie chart showed the prevalence of hypertension among surgical menopausal 
patients. 
 
 
   
73% 
27% 
Figure 7: Pie chart showed the prevalence of hypertension among surgical menopasal patients  
no hypertension,n=219 
hypertension ,n=82 
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5.3  Comparison of the demographic data and medical background between the 
hypertensive and non-hypertensive group. 
 
 
The demographic data and medical background of the patients with and without 
hypertension was compared (Table 2) 
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Table 2: Comparison of the demographic data and medical background among patients 
with and without hypertension. 
 
Variables  Hypertensive  (n=82) Non hypertensive 
(n=219) 
p value 
 n (%) n (%)  
Sociodemographic    
Race    
Malay   65 (79.30) 173 (79.00) >0.950 
b 
Chinese 15 (18.30) 42 (19.20)  
Indian 1 (1.20) 2 (0.90)  
Siamese 1 (1.20) 2 (0.90)  
     
Mean age 46.54(2.37) 46.11(3.19) 0.205  
Mean parity 3.70(2.05) 3.16(2.74) 0.069  
Mean BMI 27.05(5.33) 25.6(6.87) 0.086  
                     
HRT    
Yes  33 (40.20) 90 (41.10) 0.894
 a
 
         No  49 (59.80) 129 (58.90)  
    
Medical illness    
DM    
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Yes  0 (0.0) 4 (1.8) 0.578
 b
 
   No  82 (100.0) 215 (98.2)  
CVS    
Yes 0 (0.0) 0 (0.0) 
c
 
   No 82 (100.0) 219 (100.0)  
Smoker    
Yes 0 (0.0) 0 (0.0) 
c
 
No 82 (100.0) 219 (100.0)  
    
Family History    
Hypertension    
Yes  1 (1.2) 2 (0.9) >0.950 
b
 
   No  81 (98.8) 217 (99.1)  
DM    
Yes  1 (1.2) 0 (0.0) 0.272
 b
 
    No  81 (98.8) 219 (100.0)  
CVS    
Yes 0 (0.0) 0 (0.0) 
c
 
No 82 (100.0) 219 (100.0)  
    
a
 Pearson Chi-Square test 
b
 Fisher’s exact test 
c
 No statistics are computed because the variable is a constant 
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5.4 Duration of  onset of  hypertension 
 
 
As previous stated in section 5.2 , 82 surgical menopausal patients were noted to 
develop hypertension. The earliest  duration of onset of hypertension was 2 months      
(n :32, 10.6 %) after operation and the longest duration was 5 years ( n: 1, 0.3%). The 
mean duration of onset of hypertension was 5.65 months +/-8.44  months post surgery . 
 
The Kaplan –Meier Hypertension Survival Analysis was used to predict the probability 
of the onset of hypertension among the surgical menopausal patient. The median 
hypertension survival time could not be reported as the prevalence of hypertension 
among this group of patients was less then  50%, and the survival probability did not 
drop to 0.5 (50%) or below ( as showed in Figure 8 ). 
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Figure 8: Kaplan-Meier curves of hypertension survival estimate among post-surgical 
menopausal women in Hospital USM (n=301). 
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5.5 Factors associated with the development of hypertension 
 
From the univariate  analysis as stated in  Table 3, it was noted that factor such as age, 
parity, BMI, family history of hypertension, preexisting medical illness such as 
Diabetes Mellitus, smoking and hormone replacement therapy were  not significantly 
associated  with the development of hypertension in post surgical menopausal patient. 
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6.0 DISCUSSION 
 
 
Postmenopausal status was an independent risk factor for hypertension. (Ying Zhou et 
al., 2015). It can be natural menopause or surgically menopause women, the implication 
of that for both group of women can be the same, they can presented with climacterics 
symptoms ,psychological genitourinary symptoms, skeletal complains and 
cardiovascular complication.  
 
In this study, more evaluation and related demographic factors with background of 
medical illness, specifically hypertension and Diabetes Mellitus were studied. 
Hypertension is a major factor risk factor for developing cardiovascular disease such as 
Ischemic heart disease which can cause sudden death. Cardiovascular disease is 
currently leading cause of mortality among postmenopausal women.  
 
 In this study, surgical menopausal women were selected retrospectively who attend 
Gynaecology clinic University Sains Malaysia Hospital to determine factors associated 
with the development of hypertension among post-surgical menopause women between 
January 2000 to December 2010 at Kubang Kerian, Kelantan. 
 
Overview of surgical menopausal women at Hospital University Sains Malaysia, Most 
of the patients in University Sains Malaysia Hospital went through TAHBSO (97.0%, n: 
292) while another three percent had BSO (n: 9). 
 47 
 
The majority of women went through operation had uterine fibroid (86.7%), followed 
by adenomyosis (5.6%) and endometriosis (4.3%).This is consistent with most literature 
review uterine fibroid is the most common gynaecology tumour (prevalence 20-25%). 
 
In term of age, mean age of the patient in the study population was 46.2 years. This is 
consistent with most studies, as TAHBSO or BSO is considered for women after the age 
of 45 years old. We opted for conservative and medical management of this 
gynaecology disorder before embarked on surgical option which would render the 
patient surgically menopause.  
 
Most patient underwent TAHBSO, 97% ( n: 292), only 9 patient (3.0%) underwent 
BSO. The minority group , mostly operation due to Endometriosis, they have to 
underwent multiple operation for symptomatic causes and finally both ovaries were 
removed at premenopausal age. 
 
Otherwise, in term of BMI, mean BMI of the patient was 26.0 +/- 6.5 kg/m2, which 
included in overweight group. This finding consistent with in another study at northeast 
China found that overweight and obesity were associated with  a 1.97-fold and 2.97-fold 
increased for hypertension respectively (Ying Zhou at. al.,  Maturitas 80 (282–287.) 
2015). 
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Regarding ethnicity, majority patient are of Malay ethnicity 79% (n: 238). Followed by 
Chinese 18.94% (n=57 ) . This is due to the study population were observed in Kelantan, 
where the majority were Malay. 
 
Most of the patient were nulliparous and had low parity , nulliparous 18.3% (n:55) , 
followed by parity four 16.9 % (n: 51), parity three ,16.3 % (n:49), parity one 11.3%    
(n: 34) . These findings are comparable to most reported studies, as uterine fibroid and 
endometriosis are significantly associated with nulliparous and low parity.  
 
Patient who received Hormon Replacement Therapy 59.1% ( n : 178). Otherwise 40.9% 
( n: 123) of patient did not received HRT. Most patient were given HRT due to the 
climacteric symptoms after excluded the risk of breast carcinoma in selected HRT 
group. Another 40.9 % group who did not received HRT, refused HRT and family 
history of breast carcinoma after full counseling given. In postmenopausal women, 
treatment of arterial hypertension and glucose intolerance should be priorities. 
Observational studies and randomized clinical trials suggest that hormone replacement 
therapy (HRT) started soon after the menopause may have cardiovascular benefit. 
 
Most of patient did not had preexisting Diabetes Mellitus , family history of 
hypertension and cardiovascular disease and non-smoking, as majority were without 
any comorbid prior to operation . ). Furthermore, all women do not have CVS and were 
the non-smoker. Thus, no statistics were computed because the variables were constant. 
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Out of the 301 patient, only 82 of them (27.0%) were having hypertension and 219 
(73.0%) patient were free of hypertension. Comparison between demographic data and 
medical background  between hypertension and non hypertension group noted that there 
were no significant correlation between mean age, mean parity , mean BMI ,race, 
smoking status, medical illness such as Diabetes Mellitus, HRT, and family history of 
Hypertension, Diabetes Mellitus and cardiovascular disease with the development of 
hypertension .  
 
This study result was dissimilar with study done by Ying Zhou 2015  at china , which 
stated that other known risk factors for hypertension included body mass index (BMI), 
abdominal obesity, family history of cardiovascular disease among the first-degree 
relatives, a personal history of diabetes, and high triglyceride. Time frame of the study 
may need to extend up to 20 years in future ,to follow up  and evaluate patient outcome. 
 
For patient who developed hypertension, only 33 patients were on HRT (40.20%) and   
49 patients were not on HRT (59.80%). However, in non hypertensive patients , 90 
patients with HRT(41.0%)  and 129 patients not on HRT(58.9%), This statistical study 
showed that no significant relation between development of hypertension and patients 
on HRT. Patients on HRT or not did not influenced the development of hypertension in 
surgical menopausal women .  
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There were no  significant relationship between family history of medical disease such 
as hypertension, Diabetes Mellitus, cardiovascular disease, medical illness such as 
hypertension and Diabetes Mellitus, and smoking with development of hypertension. 
This is due to most of the patients were premorbid healthy without any medical illness. 
 
The overall cumulative hypertension survival probability curve for 301 post-surgical 
menopause women from 2001-2010 was shown by Kaplan-Meier curve in Figure 8. The 
Kaplan –Meier Hypertension Survival Analysis was used to predict the probability of 
the onset of hypertension among the surgical menopausal patient. The median 
hypertension survival time could not be reported as the prevalence of hypertension 
among this group of patients was less then  50%, and the survival probability did not 
drop to 0.5 (50%) or below. May need larger sample size and longer duration of the 
study to positively predict the development of hypertension. 
 
There are five associated factors which were studied to find the association with the 
development of hypertension among surgical menopausal women. Among 301 surgical 
menopausal women involved in this study, only 82 women (27.2%) developed 
hypertension while 219 women (72.8%) were non-hypertensive. The majority of the 
women were Malay (79.1%) and Chinese (18.9%), while Indian and Siamese were only 
1.0% respectively. Among the hypertensive women, 79.3% were Malay, and 18.3% 
were Chinese. However, there was no significant association between race and 
hypertension development (p>0.950). 
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7.0 CONCLUSION 
 
 
Overall 301 post-surgical menopausal women were included in this study. The mean 
age of the women was 46.2 years old. In this study, we found that most patients had 
gone through TAHBSO (97.0%) while another three percent (3%) had BSO. The 
majority of women had a fibroid (86.7%), followed by adenomyosis (5.6%), 
endometriosis (4.3%). The study showed  ,there are no significant relationship between 
hypertension in post-surgical menopause in BMI, parity, ethnic group, HRT, underlying 
medical illness (DM and CVS), smoking status, family history of hypertension, DM and 
CVS using Pearson Chi-square test and Fisher exact test. The overall cumulative 
hypertension survival probability curve for 301 post-surgical menopause women from 
2000-2010 was shown by Kaplan-Meier curve, the median hypertension survival time 
could not be reported as hypertensive events occurred less than 50% and the survival 
probability did not drop to 0.5 (50%) or below, which mean no median survival because 
most patients survived without hypertension in post-surgical menopause women . The 
overall cumulative survival probability for women who had TAHBSO higher than 
cumulative survival probability for women who had undergone BSO. 
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8.0 LIMITATION OF STUDY 
 
 
It is a retrospective study; all data is extracted from HUSM medical record department. 
The data is from year January 2000 to December 2010 in gynaecology Clinic at HUSM. 
The incomplete or missing record was discarded. Same of the patient, after 
hysterectomy and bilateral oophorectomy or bilateral oophorectomy, follow up else way 
and no record or latest update available at HUSM. The sample population in this study 
was limited to postmenopausal women who attended gynaecology clinic only, and it 
does not include representative the whole population of Malaysia 
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9.0 RECOMMENDATION  
 
 
This is an interesting and important subject to study, which needs larger sample size and 
includes multiracial involvement and involving others selected state in Malaysia with a 
comparable number. 
 
Post-surgical menopause women should receive education and counselling on lifestyle 
modification to reduce the risk of hypertension and subsequently reduce risks of 
uncontrolled hypertension complication such as cardiovascular disease, stroke, and 
renal disease. Evidence-based prevention for the diseases noted above include lifestyle 
management, cessation of smoking, curtailing excessive alcohol consumption, a healthy 
diet and moderate exercise, as well as mentally stimulating activities. Beside that , 
healthy women aged 50–59 years, estrogen therapy  can decreases coronary heart 
disease and all-cause mortality; this interpretation is entirely consistent with results 
from other randomized, controlled trials and observational studies. Thus. as part of a 
comprehensive strategy to prevent chronic disease after menopause, menopausal 
hormone therapy, particularly estrogen therapy may be considered as part it. 
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11.0 APPENDICES  
 
 
Appendix 1: Clinical Research Form (CRF)   
 
Department of Obstetrics and Gynaecology 
Faculty Health Science 
Hospital University Science Malaysia 
Kelantan 
 
DATA COLLECTION SHEET 
 
DEMOGRAPHY PROFILE 
1. Identification data  
Age : 
Race : 
 
2. Biometric measurements 
Weight  on admission : 
Height on admission : 
BMI : 
Blood pressure on admission: 
 64 
 
Blood pressure on the first  visit  to clinic : BP            :  
                                                               Duration : 
Blood pressure on the latest  visit:    BP                : 
                                                               Duration  : 
 
 3. Socio-economic profile 
Status  : single/married/divorced 
Job   : yes, state the occupation_________________ 
          : no 
 
4. Reproductive profile 
Menarche : 
Parity: 
First child : 
Last child : 
 
5. Menopausal profile 
Operation date  : 
Operation performed  : 
Indication : 
 65 
 
HPE report  : 
HRT: yes/no 
 
6. Medically related illness profile 
HPT: yes/no 
DM:  yes /no 
Heart disease: yes/no 
Smoker: yes/no 
 
7. Family profile  
HPT: yes/no 
DM: yes/no 
Heart disease: yes /no 
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: 2"" March 2017 
: Meeting Room, Division of Research & Innovation, 
USM Kampus Kesihatan. 
: 9.00 a.m- 2.30 p.m 
:355 
tJniversitl Salns Malaysia 
Ka1npu!» Kc~ihm;m, 
tli t .'in f\uh;m ).t t\~rian. 
l\ch•ntan. ~lahty,ia 
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Members of Committee of the Jawatankuasa Etika Penyelldikan (Manusia), JEPeM Universiti Sains Malaysia who reviewed 
the protocol/ documents are as follows: 
Member Occupation Male/ llck (.f) if present Female when above (Title and Name) (Designation) (M/F) items, were 
reviewed 
Chairperson : 
Professor Dr. Hans Am in Van Chairperson of Jawatankuasa Et ika M ,( 
Rostenberghe Penyelldikan (Manusia), JEPeM USM (Chairperson) 
Secretary: 
Mr. Mohd Bazlan Hafidz Mukrim Science Officer M ., 
Members : 
1. Assoc. Prof. Or. Allan Husln Lecturer, School of Medical Sciences M ., 
2. Assoc. Prof. Or . Has.ina Taib Lecturer, School of Dental Sciences F ,( 
3. Assoc. Prof. Or . Mohtar Ibrahim lecturer, School of Medical Sciences M ., 
<1. Prof. Or. Narazah Mohd Yusoff Lecturer, Advanced Medical and Dental F ., 
Institut e (AMOI) 
s. Prof. Dr. Nik Hazllna Nik Hussain Lecturer, School of Medical Sciences F ., 
6. Mrs. Norleha Mohd Noor Execullve secretary, School of Dental F ., 
Sciences 
7. Associate Professor Oleksandr Lecturer, School of Health Sclences M ., 
Krasilshchlkov 
8. Or. Soon Lean Keng Lecturer, School of Health Sclettces F ., 
9. Mrs. Zawiah Abu Bakar Community Representative F ., 
10. Prof. Or. Zeehaida Mohamed Lecturer, School of Medical Sciences F ., 
Jawatankuasa Etlka Penyelidlkan (Manusia), JEPeM-USM Is in complbonce with the Dedaration of Helsinki, International 
Conference on Harmonization (ICH) Guidelines, Good Clinical Practice (GCP) Standards, Council for International 
Organizations of Medical Sdencu {CIOMS) Guidelines, World Health Organization (WHO) Standards and Operational 
Guidance for Ethics Review of Health-Related Research and Surveying and Evaluating Ethical Review Practices, EC/IRB 
Standard Operating Procedures (SOPs), and local Regulations and Standards In Ethical Review. 
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PROFESSO DR,til SAM IN VAN ROSTENBERGHE 
Chairperson 
Jawatankuasa Etika Penyelidikan (Manusla), JEPeM 
Unlversiti Sa ins Malaysia 
